Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification
Cancer Network,
Results: Plasma glutamine levels were measured in a total of 125 patients with localized prostate cancer prior to RP.